Platelet-derived extracellular vesicles induced through different activation pathways drive melanoma progression by functional and transcriptional changes
2024

How Platelet-Derived Extracellular Vesicles Affect Melanoma Progression

Sample size: 15 publication 10 minutes Evidence: moderate

Author Information

Author(s): Tavukcuoglu Zeynep, Butt Umar, Faria Alessandra V. S., Oesterreicher Johannes, Holnthoner Wolfgang, Laitinen Saara, Palviainen Mari, Siljander Pia R-M

Primary Institution: University of Helsinki

Hypothesis

Different activation pathways of platelets lead to the production of distinct extracellular vesicles that influence melanoma progression.

Conclusion

Platelet-derived extracellular vesicles can enhance melanoma cell proliferation and invasion, suggesting potential therapeutic targets in cancer treatment.

Supporting Evidence

  • CRP and FFV PEVs significantly enhanced proliferation in both melanoma cell types.
  • CRP PEVs increased invasion in A2058 spheroids.
  • PEVs altered the tetraspanin profiles of cancer EVs from melanoma spheroids.

Takeaway

Platelets can help cancer cells grow and spread by sending tiny packages called extracellular vesicles, which change how the cancer cells behave.

Methodology

The study used two human melanoma cell lines in 3D spheroid cultures and analyzed the effects of different platelet-derived extracellular vesicles on cancer hallmark functions.

Potential Biases

Potential bias in the selection of platelet activation pathways and their effects on different melanoma cell lines.

Limitations

The study primarily focused on in vitro models, which may not fully replicate in vivo conditions.

Participant Demographics

Platelet concentrates were derived from four healthy donors.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s12964-024-01973-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication